drugset

drugset / Trial / NCT05624528

A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder

NCT05624528 ↗

Phase 2 Active not recruiting 49 enrolled University of Chicago

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary aim of the present study is to examine the efficacy and safety of tolcapone in adults with moderate to severe OCD.

Timeline

Start: 2023-06-22
Primary completion: 2026-06
Completion: 2026-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tolcapone	Unknown	200 mg	—

Indications